1. Home
  2. SNV vs CYTK Comparison

SNV vs CYTK Comparison

Compare SNV & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Synovus Financial Corp.

SNV

Synovus Financial Corp.

HOLD

Current Price

$52.42

Market Cap

7.3B

Sector

Finance

ML Signal

HOLD

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$62.51

Market Cap

8.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNV
CYTK
Founded
1888
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.3B
8.0B
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
SNV
CYTK
Price
$52.42
$62.51
Analyst Decision
Buy
Strong Buy
Analyst Count
15
15
Target Price
$57.93
$77.87
AVG Volume (30 Days)
795.1K
1.8M
Earning Date
01-21-2026
11-05-2025
Dividend Yield
2.99%
N/A
EPS Growth
143.15
N/A
EPS
5.35
N/A
Revenue
$2,291,796,000.00
$87,211,000.00
Revenue This Year
$30.53
$361.33
Revenue Next Year
$4.80
$65.14
P/E Ratio
$9.77
N/A
Revenue Growth
31.11
2609.26
52 Week Low
$35.94
$29.31
52 Week High
$61.06
$69.33

Technical Indicators

Market Signals
Indicator
SNV
CYTK
Relative Strength Index (RSI) 66.43 49.62
Support Level $51.98 $59.37
Resistance Level $53.47 $63.80
Average True Range (ATR) 1.02 2.56
MACD 0.09 -0.44
Stochastic Oscillator 75.02 42.46

Price Performance

Historical Comparison
SNV
CYTK

About SNV Synovus Financial Corp.

Synovus Financial Corp provides commercial and consumer banking in addition to a full suite of specialized products & services such as private banking, treasury management, wealth management, mortgage services, premium finance, asset-based lending, structured lending, capital markets, & international banking to clients through the wholly-owned subsidiary bank, Synovus Bank, and other offices in Alabama, Florida, Georgia, South Carolina, and Tennessee. It has four segments Wholesale Banking, Community Banking, Consumer Banking, and Financial Management Services, out of which the majority is from the Wholesale banking segment.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: